With only 15% of New York's healthcare providers ready for e-Rx of controlled substances, New York legislators have agreed to push back the March 27 deadline by one year.
A group of 55 pharmacies located mainly in Pennsylvania has turned to the courts to resolve reimbursement differences with Catamaran.
A pharmacist's failure to counsel can result in severe, life-changing consequences for the patient.
If the draft of the legislation was aimed at misleading the voters, as one of the drafters appears to have admitted, such conduct could constitute gross negligence.
Paper is about to become history in one of the largest prescription drug markets in the country.
Among four New York retail chains, only 21% of store-brand supplements tested contained the plant material named on their labels.
FDA is seeking to learn how these Wallcur products, which are not sterile and should not be injected in humans or animals, entered the supply chain.
Agency will use guidance in 2015 to address “key policy issues.”
A judge has reinstated the pharmacy license of a former Rhode Island state senator who mistakenly gave morphine to an infant and a toddler.